The use of automated insulin delivery systems (AID) is standard of care for people with type 1 diabetes. However, the limited capacity of insulin pump cartridges, which can hold 1.6-3.0mL or the ...

Manchester United have handed an indefinite ban to a supporter who assaulted Frank Ilet. Ilet has garnered a huge social media following over the past year as he known as the Man Utd fan refusing to ...

Investing.com - Stifel resumed coverage of Beta Bionics, Inc. (NASDAQ:BBNX) with a Buy rating and a price target of $26.00 on Monday. Currently trading at $20.24, the stock sits within analysts’ ...

Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's upcoming ...

Beta Bionics plans to integrate its iLet Bionic Pancreas with Abbott's upcoming dual glucose-ketone sensor for enhanced diabetes management. Beta Bionics, Inc. has announced plans to integrate its ...

“We added a learning layer above that.” The iLet requires only one input—the user’s weight—and calculates insulin doses every five minutes throughout the day and night. Analysts are expecting revenue ...

Please provide your email address to receive an email when new articles are posted on . The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with type 1 ...

Beta Bionics' flagship product, the iLet Bionic Pancreas, is an autonomous insulin delivery system that streamlines diabetes management and reduces the burden on patients, caregivers and physicians.